CBIO Crescent Biopharma, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 5, 2026 10-K/10-Q Tem 30, 2026
$13,87
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$8,7252 haftanın en düşüğü
$27,4152 haftanın en yükseği
Piyasa Değeri (MRQ)
$385M
P/E
-28.3
Hisse Başına Kâr
$-0.59
Gelir
$11M
rozetleriniz
52 Haftlık Aralık
$9–$27
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$31
P/E
-28.3
ROE
-90.0%
Net Kâr Marjı
-1419.6%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CBIO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$13.87
Piyasa Değeri (MRQ)
$385M
P/E
-28.3
Hisse Başına Kâr
$-0.59
Gelir
$11M
ROE
-90.0%
52 Haftlık Aralık
$9–$27
CBIO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 16 Haziran 2025 | 1-for-100 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$11M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-0.592019-12-31 → 2024-12-31
Serbest Nakit Akışı$-72M2016-12-31 → 2025-12-31
Net kar marjı-1419.6%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CBIO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -28.35Y ort. ≈-186.2 | ≈-186.2 | · | · | |
| P/S (F/S) | 35.35Y ort. ≈436476.1 | ≈436476.1 | 144.0 | Düşük değerli | |
| F/D (MRQ) | 2.45Y ort. ≈235.3 | ≈235.3 | 3.0 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -5.25Y ort. ≈-195.4 | ≈-195.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -5.35Y ort. ≈-195.6 | ≈-195.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.95Y ort. ≈218.3 | ≈218.3 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CBIO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | -1407.5%5Y ort. ≈-115708.9% | ≈-115708.9% | -2380.1% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | -1407.5%5Y ort. ≈-115708.9% | ≈-115708.9% | -2380.1% | Aynı seviyede | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -1401.2% | · | -5050.3% | En üst düzey | |
| Net Profit Margin (Net Kâr Marjı) | -1419.6%5Y ort. ≈-109533.6% | ≈-109533.6% | -2240.9% | Aynı seviyede | |
| ROA | -111.6%5Y ort. ≈-87.8% | ≈-87.8% | -40.8% | Zayıf | |
| ROE | -90.0%5Y ort. ≈-447.8% | ≈-447.8% | -52.8% | Zayıf | |
| ROIC | -76.2% | · | -39.0% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CBIO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.75Y ort. ≈5.7 | ≈5.7 | 12.9 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 6.45Y ort. ≈5.5 | ≈5.5 | 10.5 | Aynı seviyede |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CBIO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -86.7%5Y ort. ≈-89.6% | ≈-89.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 424.9% | · | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 1.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CBIO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.15Y ort. ≈0.0 | ≈0.0 | 0.0 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 1.2 | · | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$157.2K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$96.00
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Oca 13, 2023 | $24,00 | USD | ≈55.3% |
| Eyl 21, 2022 | $143,00 | USD | ≈223.4% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.05%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $-0.74 | $-0.81 | 8.7% | |
| 31 Mart 2026 | $-0.70 | $-0.97 | 27.5% | |
| 31 Aralık 2025 | $-0.54 | $-2.57 | 79.0% | |
| 30 Eylül 2025 | $-1.27 | $-2.02 | 37.2% | |
| 30 Haziran 2025 | $-4.93 | $-1.80 | -174.2% | |
| 31 Mart 2025 | $-4.00 | $-5.10 | 21.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.37 | $0.08 | $0.60 | $0.79 | $1.56 | $2.62 | $3.55 | $4.76 | $3.48 | $1.52 | $2.12 | $2.68 | |
| Revenue / Share | · | · | $0.00 | $0.00 | $0.02 | · | · | · | · | · | · | $0.81 | |
| Cash Flow / Share | · | $-0.48 | $-0.55 | $-0.88 | $-1.12 | · | · | · | · | · | · | $-0.23 | |
| Cash / Share | $7.74 | $0.17 | $0.65 | $0.88 | $1.73 | $2.80 | $3.64 | $4.86 | $3.61 | $1.72 | $2.46 | $2.91 | |
| EPS (TTM) | $-0.49 | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | $-0.75 | $-0.75 | $-0.75 | $-0.71 | $-0.60 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | · | 64,483,958 | 64,483,848 | 64,457,233 | · | 64,349,709 | 64,276,184 | 60,350,127 | · | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 64,483,958 | 64,483,848 | 64,522,257 | · | 64,349,709 | 64,276,184 | 64,457,233 | · | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | · | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | · | · | · | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | · | · | · | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | · | · | · | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | · | · | · | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.88 | · | · | $8.40 | $10.02 | · | · | · | $0.31 | $0.45 | · | $0.72 | $0.85 | $0.97 | · | $0.92 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.16 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $6.18 | · | · | $9.59 | $10.99 | · | · | · | $0.35 | $0.49 | · | $0.77 | $0.90 | $1.01 | · | $0.98 | |
| EPS (TTM) | $-0.59 | $-0.49 | · | $-0.59 | $-0.59 | $-0.59 | · | $-0.49 | $-0.48 | $-0.45 | · | $-0.64 | $-0.66 | $-0.78 | · | $-1.02 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-69M | $-54M | $-42M | · | $-40M | $-39M | $-37M | · | $-38M | $-37M | $-42M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | · | · | · | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -30.5 | -37.5 | · | -20.2 | -27.4 | -35.6 | · | -34.7 | -58.3 | -666.7 | · | -234.4 | -263.6 | -161.5 | · | -53.9 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | · | · | · | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| Earnings Yield | -3.3% | -2.7% | · | -5.0% | -3.7% | -2.8% | · | -2.9% | -1.7% | -0.15% | · | -0.43% | -0.38% | -0.62% | · | -1.8% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $11M | · | $10.0K | $75.0K | $1M |
| Faaliyet Kâr Marjı % | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% |
| Net Gelir | $-154M | $-38M | $-37M | $-47M | $-63M |
| Seyreltilmiş Hisse Başı Kâr | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Cari Oran | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-72M | $-31M | $-35M | $-47M | $-58M |
Kurumsal Sahipler (13F) 82 dosya · $526.1M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
82
Tutulan Değer
$526.1M
Yeni pozisyonlar
32
Çıkan pozisyonlar
12
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 32 (+15 önceki Ç'ye göre) | 12 (+2 önceki Ç'ye göre) | 17 (0 önceki Ç'ye göre) | 14 (+6 önceki Ç'ye göre) | +4.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $74.403.252 | 4.133.514 | 14,14% | Hisse senetleri |
| BVF INC/IL | $49.477.734 | 2.748.763 | 9,40% | Hisse senetleri |
| Fairmount Funds Management LLC | $49.461.588 | 2.747.866 | 9,40% | Hisse senetleri |
| Venrock Adviser, LLC | $38.404.368 | 2.133.576 | 7,30% | Hisse senetleri |
| Logos Global Management LP | $34.200.000 | 1.900.000 | 6,50% | Hisse senetleri |
| FCPM III SERVICES B.V. | $30.201.336 | 1.677.852 | 5,74% | Hisse senetleri |
| Balyasny Asset Management L.P. | $29.932.506 | 1.662.917 | 5,69% | Hisse senetleri |
| Vestal Point Capital, LP | $29.340.000 | 1.630.000 | 5,58% | Hisse senetleri |
| Opaleye Management Inc. | $23.748.318 | 1.319.351 | 4,51% | Hisse senetleri |
| BlackRock, Inc. | $22.891.716 | 1.271.762 | 4,35% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $20.880.000 | 1.160.000 | 3,97% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.819.590 | 767.755 | 2,63% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.269.462 | 403.859 | 1,38% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $6.923.843 | 384.576 | 1,32% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $6.813.126 | 378.507 | 1,30% | Hisse senetleri |
| RTW INVESTMENTS, LP | $6.711.408 | 372.856 | 1,28% | Hisse senetleri |
| NEXTBio Capital Management LP | $6.711.408 | 372.856 | 1,28% | Hisse senetleri |
| VANGUARD GROUP INC | $6.612.021 | 557.506 | 1,26% | Hisse senetleri |
| Remedium Capital Partners, LLC | $6.502.500 | 361.250 | 1,24% | Hisse senetleri |
| STATE STREET CORP | $5.680.566 | 315.587 | 1,08% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $5.446.224 | 302.568 | 1,04% | Hisse senetleri |
| Point72 Asset Management, L.P. | $5.400.000 | 300.000 | 1,03% | Hisse senetleri |
| MARSHALL WACE, LLP | $3.857.400 | 214.300 | 0,73% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $3.724.956 | 206.942 | 0,71% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.398.454 | 188.803 | 0,65% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $3.363.732 | 186.874 | 0,64% | Hisse senetleri |
| STEMPOINT CAPITAL LP | $3.282.876 | 182.382 | 0,62% | Hisse senetleri |
| UBS Group AG | $3.153.276 | 175.182 | 0,60% | Hisse senetleri |
| NORTHERN TRUST CORP | $2.498.004 | 138.778 | 0,47% | Hisse senetleri |
| Exome Asset Management LLC | $2.299.842 | 127.769 | 0,44% | Hisse senetleri |
| SECTORAL ASSET MANAGEMENT INC | $2.183.400 | 121.300 | 0,42% | Hisse senetleri |
| Woodline Partners LP | $1.700.784 | 94.488 | 0,32% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.354.050 | 75.225 | 0,26% | Hisse senetleri |
| Burkehill Global Management, LP | $1.332.000 | 74.000 | 0,25% | Hisse senetleri |
| Blackstone Inc. | $1.127.646 | 62.647 | 0,21% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.063.872 | 59.104 | 0,20% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $914.832 | 50.824 | 0,17% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904.644 | 50.258 | 0,17% | Hisse senetleri |
| Nuveen, LLC | $857.322 | 47.629 | 0,16% | Hisse senetleri |
| Bank of New York Mellon Corp | $824.004 | 45.778 | 0,16% | Hisse senetleri |
| Stonepine Capital Management, LLC | $720.000 | 40.000 | 0,14% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $464.778 | 25.821 | 0,09% | Hisse senetleri |
| RHUMBLINE ADVISERS | $458.766 | 25.487 | 0,09% | Hisse senetleri |
| MOORE CAPITAL MANAGEMENT, LP | $450.000 | 25.000 | 0,09% | Hisse senetleri |
| Squarepoint Ops LLC | $434.988 | 24.166 | 0,08% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $410.490 | 22.805 | 0,08% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $385.450 | 32.500 | 0,07% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $354.600 | 19.700 | 0,07% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $328.950 | 18.275 | 0,06% | Hisse senetleri |
| Virtus Investment Advisers, LLC | $328.644 | 18.258 | 0,06% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 başvurular | 20 Temmuz 2026 | 16,52% | Değişiklik | Pasif yatırım | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 başvurular | 20 Haziran 2025 | 0,37% | Değişiklik | · | SEC |
| 08 Mayıs 2024 | · | İlk başvuru | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 başvurular | 29 Şubat 2024 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 34 içeriden öğrenenler · 16 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 18 Eylül 2026 S | 271.765 | 0 | 3 | $-920.842 |
| Harout Semerjian | Chief Executive Officer | 12 Ocak 2024 A | 25.000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 16 Eylül 2026 S | 19.730 | 0 | 2 | $-30.172 |
| Brian M. Hahn | SVP Finance, CFO | 18 Haziran 2024 P | 70.643 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 18 Eylül 2026 S | 134.588 | 0 | 3 | $-446.912 |
| Jan Pinkas | Chief Scientific Officer | 16 Eylül 2026 S | 21.581 | 0 | 2 | $-34.949 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 16 Eylül 2026 S | 18.710 | 0 | 2 | $-33.010 |
| Ellie Eunkyung Im | Chief Medical Officer | 16 Eylül 2026 S | 21.446 | 0 | 2 | $-33.082 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 16 Eylül 2026 S | 13.631 | 0 | 2 | $-12.661 |
| Christopher Grant Doughty | Chief Business Officer | 15 Aralık 2025 A | 62.194 | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 21 Haziran 2024 P | 680.403 | 0 | 0 | $0 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 Ocak 2024 A | 138.980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 Ocak 2024 A | · | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 Kasım 2022 P | 29.161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 Kasım 2022 P | 366.078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 Ocak 2021 A | 183.115 | 0 | 0 | $0 |
| Alexandra Balcom | Yönetim kurulu üyesi | 02 Haziran 2026 A | · | 0 | 0 | $0 |
| Susan Moran | Yönetim kurulu üyesi | 02 Haziran 2026 A | · | 0 | 0 | $0 |
| Jonathan Violin | Yönetim kurulu üyesi | 02 Haziran 2026 A | · | 0 | 0 | $0 |
| David Charles Lubner | Yönetim kurulu üyesi | 02 Haziran 2026 A | · | 0 | 0 | $0 |
| Rachel K. King | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 515.194 | 0 | 0 | $0 |
| Scott Koenig | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 36.750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 5.250 | 0 | 0 | $0 |
| Mark Alan Goldberg | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 24.828 | 0 | 0 | $0 |
| Timothy R Pearson | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 24.650 | 0 | 0 | $0 |
| Patricia S Andrews | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 58.608 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Yönetim kurulu üyesi | 01 Mayıs 2024 A | 98.459 | 0 | 0 | $0 |
| James M Barrett | Yönetim kurulu üyesi | 18 Mayıs 2018 A | 4.995.664 | 0 | 0 | $0 |
| John J. Baldwin | Yönetim kurulu üyesi | 29 Haziran 2016 M | 1.210 | 0 | 0 | $0 |
| Franklin H Top JR | Yönetim kurulu üyesi | 17 Mayıs 2016 A | 12.294 | 0 | 0 | $0 |
| Michael A Henos | Yönetim kurulu üyesi | 15 Temmuz 2015 A | 469.454 | 0 | 0 | $0 |
| William M. Gust | Yönetim kurulu üyesi | 15 Ocak 2014 C | 409.947 | 0 | 0 | $0 |
| Scott D. Sandell | 10% sahip | 26 Ocak 2023 S | 2.237.196 | 0 | 0 | $0 |
| Peter J Barris | 10% sahip | 10 Mayıs 2018 X | 4.995.664 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 10 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,10% | 72.879 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,03% | 202.796 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23.282 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 544.047 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124.281 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 10.277 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83.801 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661.946 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.832 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 39.408 SH | 19 Ağustos 2026 | Günlük |
CBIO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 15 analist
AL
Medyan hedef
$28.00
+101,9%
6 40,0%
Güçlü Al
7 46,7%
Al
2 13,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-09-30Ortalama hedef $30.60 +120,6%
← Tüm hedeflerin altında
Mevcut fiyat $13.87
Düşük$27.00
Ortalama$30.60
Yüksek$35.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ZURA | · | · | · | · | · | · |
| MNPR | · | · | · | · | · | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 30, 2026